Suspected adverse reaction to compounded preparations prescribed for weight loss: two cases of cerebral venous thrombosis
- 1 March 2020
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 13 (3), e233746
- https://doi.org/10.1136/bcr-2019-233746
Abstract
We report two cases of cerebral venous thrombosis associated with the use of compounded preparations containing several active substances prescribed for weight loss. In both cases there is suspicion of additive/synergic interaction with oral contraceptives. The adverse drug reactions were considered serious, being life-threatening and causing hospitalisation for days.This publication has 29 references indexed in Scilit:
- Risk Factors for Cerebral Venous ThrombosisSeminars in Thrombosis and Hemostasis, 2016
- StrokeStroke, 2016
- Hormonal Contraceptives and Cerebral Venous Thrombosis Risk: A Systematic Review and Meta-AnalysisFrontiers in Neurology, 2015
- Cortical venous thrombosis following exogenous androgen use for bodybuildingBMJ Case Reports, 2013
- Diagnosis and Management of Cerebral Venous ThrombosisStroke, 2011
- Cerebral Venous and Sinus Thrombosis in WomenStroke, 2009
- Thrombosis of the Cerebral Veins and SinusesThe New England Journal of Medicine, 2005
- Prognosis of Cerebral Vein and Dural Sinus ThrombosisStroke, 2004
- High-Dose Corticosteroid Treatment Is Associated with an Increased Risk of Developing Cerebral Venous ThrombosisEuropean Neurology, 2003
- Cerebral Vein and Dural Sinus Thrombosis in Portugal: 1980–1998Cerebrovascular Diseases, 2001